Weighted Average Number of Shares Outstanding, Diluted of Sonnet BioTherapeutics Holdings, Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Sonnet BioTherapeutics Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 4,081,296, a 523% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 4,081,296, a 523% increase from 2024.
  • Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 655,240, a 405% increase from 2023.
  • Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 129,760, a 34% decline from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 4,081,296 +3,426,056 +523% 01 Jul 2025 30 Sep 2025 10-K 16 Dec 2025 2025 FY
Q2 2025 3,965,220 +3,335,560 +530% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q3
Q1 2025 3,921,641 +3,310,750 +542% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 2,022,818 +1,548,119 +326% 01 Oct 2024 31 Dec 2024 10-Q 13 Feb 2025 2024 Q1
Q3 2024 655,240 +525,480 +405% 01 Jul 2024 30 Sep 2024 10-K 16 Dec 2025 2025 FY
Q2 2024 629,660 -706,212 -53% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q3
Q1 2024 610,891 -139,691 -19% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q2
Q4 2023 474,699 +160,227 +51% 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025 2024 Q1
Q3 2023 129,760 01 Jul 2023 30 Sep 2023 10-K 17 Dec 2024 2024 FY
Q2 2023 1,335,872 -2,994,617 -69% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q3
Q1 2023 750,582 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q2
Q4 2022 314,472 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q1
Q2 2022 4,330,489 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q3

Sonnet BioTherapeutics Holdings, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 4,081,296 +3,426,056 +523% 01 Oct 2024 30 Sep 2025 10-K 16 Dec 2025 2025 FY
2024 655,240 +525,480 +405% 01 Oct 2023 30 Sep 2024 10-K 16 Dec 2025 2025 FY
2023 129,760 -67,702 -34% 01 Oct 2022 30 Sep 2023 10-K 17 Dec 2024 2024 FY
2022 197,462 01 Oct 2021 30 Sep 2022 10-K 14 Dec 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.